Viewing Study NCT07355205

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-31 @ 2:59 PM
Study NCT ID: NCT07355205
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-01-21
First Post: 2026-01-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Sponsor: Washington University School of Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer Stage IV View
None Non-small Cell Lung Cancer Recurrent View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-small cell lung cancer View
None Stage IV View
None Immunotherapy View
None IL-15 super agnoist View